The University of Chicago Header Logo

Connection

Clarissa Parker to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Clarissa Parker has written about Protein Kinase Inhibitors.
Clarissa Parker
Connection Strength
0.047
Protein Kinase Inhibitors
  1. Combined analysis of molecular and clinical predictors of gefitinib activity in advanced non-small cell lung cancer: epidermal growth factor receptor mutations do not tell the whole story. J Thorac Oncol. 2006 Jan; 1(1):52-60.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.